These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17637758)

  • 1. A novel role of Rac1 GTPase in JCV T-antigen-mediated beta-catenin stabilization.
    Bhattacharyya R; Noch EK; Khalili K
    Oncogene; 2007 Dec; 26(55):7628-36. PubMed ID: 17637758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between JCV large T-antigen and beta-catenin.
    Gan DD; Khalili K
    Oncogene; 2004 Jan; 23(2):483-90. PubMed ID: 14724577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.
    Gan DD; Reiss K; Carrill T; Del Valle L; Croul S; Giordano A; Fishman P; Khalili K
    Oncogene; 2001 Aug; 20(35):4864-70. PubMed ID: 11521197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms.
    Esufali S; Charames GS; Bapat B
    FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin.
    Enam S; Del Valle L; Lara C; Gan DD; Ortiz-Hidalgo C; Palazzo JP; Khalili K
    Cancer Res; 2002 Dec; 62(23):7093-101. PubMed ID: 12460931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation.
    Kim SE; Yoon JY; Jeong WJ; Jeon SH; Park Y; Yoon JB; Park YN; Kim H; Choi KY
    J Cell Sci; 2009 Mar; 122(Pt 6):842-8. PubMed ID: 19240121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.
    Olkku A; Mahonen A
    Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Wnt-driven beta-catenin stabilization revealed by quantitative and temporal imaging.
    Hannoush RN
    PLoS One; 2008; 3(10):e3498. PubMed ID: 18941539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
    Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
    Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
    Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
    Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2+-mobilization in Human Embryonic Kidney 293 cells.
    Verkaar F; van Rosmalen JW; Smits JF; Blankesteijn WM; Zaman GJ
    Cell Signal; 2009 Jan; 21(1):22-33. PubMed ID: 18929644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate Galpha13 and Wnt6-beta-catenin signaling in F9 embryonal carcinoma cells is required for primitive endoderm differentiation.
    Krawetz R; Kelly GM
    Biochem Cell Biol; 2009 Aug; 87(4):567-80. PubMed ID: 19767821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac1 augments Wnt signaling by stimulating β-catenin-lymphoid enhancer factor-1 complex assembly independent of β-catenin nuclear import.
    Jamieson C; Lui C; Brocardo MG; Martino-Echarri E; Henderson BR
    J Cell Sci; 2015 Nov; 128(21):3933-46. PubMed ID: 26403202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.